108991 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
SYNTHESIS OF GLUFOSINATE USING A HYDANTOINASE-BASED PROCESS
#2ENZYMATIC METHOD FOR THE PRODUCTION OF L-GLUFOSINATE P-ESTERS
#3AND-GATE ALLOSTERIC PROTEIN-BASED SWITCHES
#4BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF PREGABALIN INTERMEDIATES
#5ENZYMATIC DECARBAMOYLATION OF GLUFOSINATE DERIVATIVES
#6SYNTHETIC MAMMALIAN SIGNALING CIRCUITS FOR ROBUST CELL POPULATION CONTROL
#7AN ENGINEERED YEAST CELL FOR THE DELIVERY OF ANTIBIOTIC-INACTIVATING ENZYMES
#8RNA expression modulating or editing method via regulation of Cas13 protein
#9PRODUCTION CELLS
#10METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE
#11TRANSGENIC BACTERIA WITH EXPANDED AMINO ACID USAGE AND NUCLEIC ACID MOLECULES FOR USE IN THE SAME
#12HETEROLOGOUS PROTEINS WITH AXONEMAL PROTEINS
#13MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO
#14BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY
#15-based production of beta-lactamase
#16COMPOSITIONS AND METHODS FOR ENZYME IMMOBILIZATION
#17COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY
#18XANTHINE AMIDE HYDROLASE AND USE THEREOF
#194-UREIDO-5-CARBOXYL-IMIDAZOLE-AMIDE HYDROLASE AND USE THEREOF
#20PRODUCTION OF GPP AND CBGA IN A METHYLOTROPHIC YEAST STRAIN
#21MICROBIAL HOST CELLS FOR THE PRODUCTION OF HETEROLOGOUS CYANURIC ACID HYDROLASES AND BIURET HYDROLASES
#22MAMMALIAN EXPRESSION VECTORS
#23BETA-LACTAMASE VARIANTS
#24PEPTIDE ANTIGENS AND USES THEREOF
#25Fluorescence-based reporters for mutagenesis detection in
#26Beta-lactamases with improved properties for therapy
#27MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO
#28Synthetic mammalian signaling circuits for robust cell population control
#29CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME
#30Efficient Protein Expression System for Expressing Bt Insecticidal Protein
#31-based production of beta-lactamase
#32Direct detection of the active form of beta-lactam-hydrolysing enzymes by using mass spectrophotometry
#33Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same
#34Beta-lactamases with improved properties for therapy
#35Beta-lactamase variants
#36Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
#37Beta-lactamases with improved properties for therapy
#38Immobilized cycloaliphatic peptide acyltransferase and preparation method and uses thereof
#39Compositions and methods for enzyme immobilization
#40Beta-lactamases with improved properties for therapy
#41Fluorescence-based reporters for mutagenesis detection in
#42UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES
#43Recombinant polypeptides comprising selenocysteine and method for producing the same
#44Covalent tethering of functional groups to proteins
#45Modified beta-lactamases and methods and uses related thereto
#46Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
#47Biosynthetic gene cluster of carrimycin
#48Methods of producing 6-carbon chemicals via CoA-dependent carbon chain elongation associated with carbon storage
#49Beta-lactamase variants
#50Beta-lactamase variants
#51Beta-lactamases with improved properties for therapy
#52Modified creatinase
#53Beta-lactamases with improved properties for therapy
#54Non-silencing selectable marker genes and methods of use
#55Mutants of hydantoinase
#56Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
#57Hypochlorite resistant cyanuric acid hydrolases and methods of use thereof
#58-based production of beta-lactamase
#59Beta-lactamases with improved properties for therapy
#60HYBRID PROTEINACEOUS MOLECULE CAPABLE OF INHIBITING AT LEAST ONE ANTIBIOTIC AND PHARMACEUTICAL COMPOSITION CONTAINING IT
#61Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
#62Modified beta-lactamases and methods and uses related thereto
#63Beta-lactamases with improved properties for therapy
#64UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES
#65METHODS FOR PRODUCING 6-CARBON CHEMICALS VIA METHYL-ESTER SHIELDED CARBON CHAIN ELONGATION
#66Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same
#67Modified beta-lactamases and methods and uses related thereto
#68Selective advantage in fermentation
#69Covalent tethering of functional groups to proteins
#70CARBAPENEMASE AND ANTIBACTERIAL TREATMENT
#71Method for Producing L-Amino Acids Using an Alkaliphilic Bacteria
#72METHODS, COMPOSITIONS AND DEVICES FOR MAINTAINING CHEMICAL BALANCE OF CHLORINATED WATER
#73Beta-lactamases with improved properties for therapy
#74SECRETION AND FUNCTIONAL DISPLAY OF CHIMERIC POLYPEPTIDES
#75Beta-lactamases with improved properties for therapy
#76CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME
#77Non-silencing selectable marker genes and methods of use
#78Modified beta-lactamases and methods and uses related thereto
#79Modified beta-lactamases and methods and uses related thereto
#80Method for treating pancreatic cancer with vaccine
#81CHARGE-ENGINEERED ANTIBODIES OR COMPOSITIONS OF PENETRATION-ENHANCED TARGETING PROTEINS AND METHODS OF USE
#82Covalent tethering of functional groups to proteins
#83Universal protein overexpression tag comprising ramp function, and application thereof
#84Beta-lactamases with improved properties for therapy
#85Methods of producing 6-carbon chemicals via CoA-dependent carbon chain elongation associated with carbon storage
#86Modified beta-lactamases and methods and uses related thereto
#87IMMOBILIZED CYCLOALIPHATIC PEPTIDE ACYLTRANSFERASE AND PREPARATION METHOD AND USES THEREOF
#88Mutants of hydantoinase
#89Modified beta-lactamases and methods and uses related thereto
#90Prodrug activation in cancer cells using molecular switches
#91Method for measuring beta-lactam antibiotics
#92Modified beta-lactamases and methods and uses related thereto
#93METHODS AND COMPOSITIONS FOR DETECTING PROMOTER ACTIVITY AND EXPRESSING FUSION PROTEINS
#94Modified beta-lactamases and methods and uses related thereto
#95Compositions and methods for immunization against bacteria expressing a carbapenemase
#96METHODS, COMPOSITIONS AND DEVICES UTILIZING STRUCTURALLY STABLE CYANURIC ACID HYDROLASE
#97Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#98Preparation of beta-amino acids
#99Compositions comprising a dehalogenase substrate and a radionuclide and methods of use
#100METHODS FOR GENERATING POLYNUCLEOTIDES HAVING DESIRED CHARACTERISTICS BY ITERATIVE SELECTION AND RECOMBINATION
#101Compositions comprising a dehalogenase substrate and a contrast agent and methods of use
#102Multi-epitopic vaccine
#103CARBAPENEMASE AND ANTIBACTERIAL TREATMENT
#104Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#105STABILIZED ENZYME COMPOSITIONS
#106Expression cassette, recombinant host cell and process for producing a target protein
#107MATERIALS AND METHODS FOR THE MODIFICATION OF PLANT LIGNIN CONTENT
#108METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING
#109METHODS AND COMPOSITIONS FOR DETECTING PROMOTER ACTIVITY AND EXPRESSING FUSIONPROTEINS
#110Compositions comprising a dehalogenase substrate and a fluorescent label and methods of use
#111Prodrug activation in cancer cells using molecular switches
#112Polypeptides of sp. having acid endoglucanase or acid cellulase activity
#113Methods, compositions and devices utilizing structurally stable cyanuric acid hydrolase
#114METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING
#115Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#116Method for Identifying an inhibitor of plasmidic classic C beta-lactamase having extended-substrate specifity
#117Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
#118Antibodies produced in the avian oviduct
#119HOMOGENEOUS IN VITRO FEC ASSAYS AND COMPONENTS
#120Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
#121Methods, compositions and devices for maintaining chemical balance of chlorinated water
#122Inhibiton of metallo-β-lactamase by double-stranded DNA
#123Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
#124Method and system for lactose-free or lactose-reduced milk and associated products, production thereof, and associated processes
#125Sugar beet genes involved in stress tolerance
#126Primers for Use in Detecting Metallo-Beta-Lactamases
#127USE OF BETA-LACTAMASE
#128Mutants for the preparation of D-amino acids
#129Modified beta-lactamase and method for its preparation
#130METHODS AND COMPOSITIONS FOR DETECTING PROMOTER ACTIVITY AND EXPRESSING FUSION PROTEINS
#131Methods and compositions for polypeptide engineering
#132Polypeptides of sp. having glutamic peptidase activity
#133Crystal structure of CMY-10, a β-lactamase causing antibiotic resistance with extended-substrate spectrum
#134METHODS FOR GENERATING POLYNUCLEOTIDES HAVING DESIRED CHARACTERISTICS BY ITERATIVE SELECTION AND RECOMBINATION
#135Plant dihydroorotase
#136Methods And Compositions For Grafting Functional Loops Into A Protein
#137Inhibitors of viral entry screening method
#138TARGETED ENZYMES
#139Protein Design Automation for Protein Libraries
#140Method for producing protein
#141Sugar beet genes involved in stress tolerance
#142Targeted enzyme prodrug therapy
#143Compositions comprising a dehalogenase substrate and a fluorescent label and methods of use
#144Directed evolution of enzymes and antibodies
#145Lactam ring-opening enzyme and use thereof
#146Substrates for beta-lactamase and uses thereof
#147Thermally stable amidases
#148Hybrid proteins of active-site serine β-lactamase
#149Attaching substances to microorganisms
#150Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
#151Polypeptides of Alicyclobacillus sp.
#152Methods and compositions for polypeptide engineering
#153DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein and method of producing optically active amino acid
#154Mutants for the preparation of d-amino acids
#155Methods and compositions for polypeptide engineering
#156DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
#157Materials and methods for the modification of plant lignin content
#158DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
#159Methods and compositions for polypeptide engineering
#160Targeted enzymes
#161Methods and compositions for polypeptide engineering
#162Modified β-lactamases and uses thereof
#163Targeted enzyme prodrug therapy
#164Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
#165Attaching substances to microorganisms
#166Beta-lactamase CD4+ T-cell epitopes
#167Non-sporulating having parts of the gene encoding sigma G deleted
#168Polypeptides of Alicyclobacillus sp.
#169Recombinant DNA having hydantoinase gene and carbamylase gene and process for producing amino acid
#170Methods and compositions for detecting promoter activity and expressing fusion proteins
#171Generation of stabilized proteins by combinatorial consensus mutagenesis
#172Methods and compositions for polypeptide engineering
#173Beta-lactamases with improved properties for therapy
#174Beta-lactamases with improved properties for therapy